Skip to content

Multi-level Thoracic Paravertebral Block and Its Effects on Acute and Chronic Pain, and Health-Related Quality of Life after Major Breast Cancer Surgery

Thoracic Paravertebral Block and the Risk of Developing Chronic Pain after Major Breast Cancer Surgery: A Prospective Randomizeda Single-level versus ulti-level ThoracicStudy ComparingParavertebral Block

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004201
Enrollment
Unknown
Registered
2014-01-25
Start date
2015-07-05
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer in females

Interventions

Group I:Ultrasound guided multi-level thoracic paravertebral nerve block: In one group, local anesthetic will be injected in all the three levels
while in the other group, local anesthetic will be injected in one thoracic level and saline will be injected subcutaneously or intramuscularly in the other two levels.
Group II:Local anesthetic will be injected in all the three levels

Sponsors

The Chinese University of Hong Kong, Prince of Wales Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: Consenting adult ASA 1-3 patients under the age of 75 years undergoing major breast cancer surgery (which includes axillary lymph node dissection) will be recruited for this study.

Exclusion criteria

Exclusion criteria: The following patients will be excluded from the study: history of chronic pain, history of regular analgesic usage, contraindication to the use of non-steroidal anti-inflammatory drugs (NSAID), known allergy to local anaesthetic drugs, infection at the site of block placement, bleeding tendency or with evidence of coagulopathy, pre-existing neurological or muscular disorders, history of psychiatric illness, pregnant patients, pre-existing nausea or vomiting, patients who received opioid or drugs with antiemetic properties in the 24 h before surgery, patients who received radiotherapy before surgery and patients with breast pain before surgery.

Design outcomes

Primary

MeasureTime frame
Acute postoperative pain;Analgesic consumption;Quality of Recovery;

Secondary

MeasureTime frame
The incidence of chronic pain;Quality of Life;

Countries

China

Contacts

Public ContactManoj K Karmakar

Prince of Wales Hospital

karmakar@cuhk.edu.hk+852 26322737

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026